Wellington Management Company »

Caribou Biosciences shares owned by Wellington Management Company

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 314k 5.73
2023-09-30 $952k 199k 4.78
2023-03-31 $474k 89k 5.31
2022-12-31 $563k 90k 6.28

More positions owned by Wellington Management Company

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Pfizer (PFE)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Danaher Corporation (DHR)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)

View all positions for Wellington Management Company

Top funds holding Caribou Biosciences

BlackRock
Partner Fund Management
Avidity Partners Management
Vanguard Group
Point72 Asset Management
Paradigm Biocapital Advisors
Elmwood Wealth Management
Dimensional Fund Advisors
Bank of America Corporation
Candriam Luxembourg S.C.A.
Kynam Capital Management
Rokos Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Maverick Capital

View all funds holding Caribou Biosciences